Showing results (71-80 of 1,393) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|February 2, 2022
Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced CancersBenjamin Garmezy, Jinesh Gheeya, Heather Y Lin, et al.
JCO Precision Oncology|July 14, 2022
Cost-Effectiveness of Parallel Versus Sequential Testing of Genetic Aberrations for Stage IV Non-Small-Cell Lung Cancer in the NetherlandsHenri B Wolff, Elisabeth M P Steeghs, Zakile A Mfumbilwa, et al.
JCO Precision Oncology|July 14, 2022
Longitudinal Monitoring of Circulating Tumor DNA to Predict Treatment Outcomes in Advanced CancersMohamed A Gouda, Helen J Huang, Sarina A Piha-Paul, et al.
JCO Precision Oncology|July 21, 2022
Identification of KRAS Mutations in Circulating Tumor DNA in Patients With CancerKyaw Z Thein, Amadeo B Biter, Kimberly C Banks, et al.
JCO Precision Oncology|April 27, 2022
ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case SeriesMargherita Ambrosini, Marzia Del Re, Paolo Manca, et al.
JCO Precision Oncology|April 13, 2022
Circulating Tumor-Macrophage Fusion Cells and Circulating Tumor Cells Complement Non-Small-Cell Lung Cancer Screening in Patients With Suspicious Lung-RADS 4 NodulesYariswamy Manjunath, Kanve Nagaraj Suvilesh, Jonathan B Mitchem, et al.
JCO Precision Oncology|December 7, 2023
RNA-Based Homologous Recombination Deficiency Signature Detects Homologous Recombination Deficiency-RNA+ Patients With and Without Homologous Recombination Repair Gene Pathogenic Alterations in Men With Prostate CancerLandon C Brown, Jason Zhu, Elizabeth Mauer, et al.
JCO Precision Oncology|December 7, 2023
Trastuzumab Deruxtecan‒Related Interstitial Lung Disease/Pneumonitis: Computed Tomography Imaging Patterns to Guide Diagnosis and ManagementMizuki Nishino, Masahiko Kusumoto, Alexander A Bankier, et al.
JCO Precision Oncology|December 1, 2023
Nivolumab Plus Ipilimumab in Patients With Solid Tumors With ATM Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) StudyNitin Rohatgi, Michael Rothe, Pam K Mangat, et al.
JCO Precision Oncology|December 1, 2023
Homologous Recombination Deficiency Across Subtypes of Primary Breast CancerSynnøve Yndestad, Christina Engebrethsen, Andrea Herencia-Ropero, et al.
Pageof 140